Author
widya-adiarti
View
221
Download
4
Embed Size (px)
7/30/2019 Oral Cavity Neoplasma
1/42
NEOPLASMS OF THE
ORAL CAVITY
Divisi Onkologi
7/30/2019 Oral Cavity Neoplasma
2/42
ANATOMY
Lips to the junctional of hard and soft pallate
Mucosa buccal
Upper and lower alveolar bridges
Retromollar trigone 2/3 oral tongue
Floor mouth
Hard palate
7/30/2019 Oral Cavity Neoplasma
3/42
7/30/2019 Oral Cavity Neoplasma
4/42
EPIDEMIOLOGI
Risk factor alcohol, tobacco
95% Ca sel skuamosa
Pria : Wanita = 1:2
95% > 40 tahun; umur rata-rata 60 tahun the human papillomavirus (HPV) may play a role in
the etiology of oral cavity
7/30/2019 Oral Cavity Neoplasma
5/42
7/30/2019 Oral Cavity Neoplasma
6/42
7/30/2019 Oral Cavity Neoplasma
7/42
7/30/2019 Oral Cavity Neoplasma
8/42
7/30/2019 Oral Cavity Neoplasma
9/42
Lesi mukosa putih ataupun merah membutuhkan biopsi
Lesi leukoplakia benigna dan tidak menghilang setelah
menghentikan tobako, pengobatan masih tidak jelas.
Surgical excision, laser excision, and similar techniques have all
been used with some degree of success. Nonsurgical
approaches, such as topical vitamin A therapy, also have been
tried, with complete response rates in the 10% to 27% range
and partial response rates in 54% to 90% of patients.
The side effects were minimal, but leukoplakia recurred in 50%
of patients after discontinuation of the medication
7/30/2019 Oral Cavity Neoplasma
10/42
7/30/2019 Oral Cavity Neoplasma
11/42
RADIATION THERAPY
Radiation therapy and surgery have equal success in controlling T1
lesions of the oral cavity.
Treatment options must be determined by numerous factors, including
the location, the patient's physical condition and social and economic
situation, and the experience of those delivering the care.
Radiation therapy tends to provide a better functional result with superior
speech and swallowing, but significant disadvantages of radiation
therapy are diminution of taste, xerostomia, and the protracted nature ofthe treatment course.
Unlike surgery, a curative dosage of radiation therapy requires at least 6
weeks of treatment, and this can affect the treatment choice.
When considering oral cavity cancers, the highest rate of complicationsrelated to external beam radiation occurs in patients with floor-of-mouth
cancer; historically, in one fourth or more of these patients,
osteoradionecrosis of the mandible developed.
Newer techniques brachytherapy and intensity-modulated radiation
therapy (IMRT) more focused targeting and reduced complications
7/30/2019 Oral Cavity Neoplasma
12/42
CHEMOTHERAPY
Although the combination of radiation therapy and
surgery provides a better chance for cure for stage
III and IV disease than does either modality alone,
substantial evidence suggests that the addition of
concomitant chemotherapy to postoperative
radiation therapy improves locoregional control andsurvival in these patients
7/30/2019 Oral Cavity Neoplasma
13/42
BUCCAL CARCINOMA
uncommon cancer
Buccal carcinomas occur most commonly in 70-year-oldmen and are found in a region of cheek leukoplakia.
The exophytic lesions may have a relatively benign
appearance and may not penetrate into the soft tissues
of the cheek until they are relatively large. The ulcerative lesions, however, penetrate early and
make cure more difficult because of their involvement of
adjacent muscle, bone, and skin
Because no natural barriers to tumor penetration exist inthe cheek, cure rates are not as good as one might
expect in a region so easily inspected.
7/30/2019 Oral Cavity Neoplasma
14/42
As with most oral cavity neoplasms, T1 lesions can be treated either
with surgery or radiation therapy, although resection and coverage of
the area with a split-thickness skin graft may be more convenient and
expedient.
Because T1 lesions are rare, large series comparing treatmentmodalities cannot be found. Three-year survival rates for T1 and T2
lesions are approximately 80% and 60%, respectively, and
depending on the extent of the lesions, marginal or rim
mandibulectomy or partial maxillectomy or both may be necessary
for adequate margins Surgery plus radiation therapy is the treatment of choice for stage III
and IV disease. The extent of resection of these larger lesions is
variable, but may include resection of the maxilla or mandible,
parotidectomy, neck dissection, or a combination of these.
Reconstruction is with free (radial forearm) or regional myocutaneous(temporalis, pectoralis major) flaps or with an osteomyocutaneous
free flap if bone is needed.
7/30/2019 Oral Cavity Neoplasma
15/42
HARD PALATUM CARCINOMA
Primary malignancies of the hard palate are uncommon
with a relatively equal incidence of squamous cell
carcinoma and salivary gland malignancies.
Because nodal metastases are retropharyngeal, it is
unnecessary to be concerned with prophylactic necktherapy.
Only those patients with T4 lesions begin to approach
an incidence of nodal metastases (25%) for which
prophylactic neck irradiation would be considered.
Although distant metastases are rare with squamous
cell carcinoma of the hard palate, an incidence of 12%
has been found in patients with salivary gland tumors
7/30/2019 Oral Cavity Neoplasma
16/42
Radiation therapy has been reported to be as effective as
surgery in treating T1 and T2 lesions, for those of both
salivary gland and squamous etiology.
It is probably true, however, that T1 lesions are most
easily treated by excision.
For the larger T3 and T4 lesions (the 5-year survival rate
decreases from 85% for a T1 lesion to 30% for a T4
lesion), the treatment of choice is a combination of
surgery and radiation therapy
Partial or total maxillectomy is often required, and the
traditional reconstruction has been with a prosthetic
obturator, requiring preoperative evaluation by aprosthodontist
7/30/2019 Oral Cavity Neoplasma
17/42
ORAL TONGUE
In deciding on treatment modalities for oral tongue
cancer, the same factors are applicable as for most otherhead and neck sites.
T1-2 lesions can be treated by surgery or radiationtherapy, and T3-4 lesions do best with combinationtherapy.
Radiation treatment alone achieves control rates of 86%for T1 and 75% for T2 lesions.
Because of the high complication rate associated withcurative doses suggested a policy of initial surgery, with
postoperative radiation therapy being reserved forpatients with a suspected high rate of local or neckfailure.
7/30/2019 Oral Cavity Neoplasma
18/42
7/30/2019 Oral Cavity Neoplasma
19/42
7/30/2019 Oral Cavity Neoplasma
20/42
7/30/2019 Oral Cavity Neoplasma
21/42
7/30/2019 Oral Cavity Neoplasma
22/42
7/30/2019 Oral Cavity Neoplasma
23/42
1. The incisive foramina house the
A. Greater palatine vessels and nerves
B. Sphenopalatine nerve
C. Palatine nerves and nasopalatine arteries
D. Anterior and posterior superior alveolar nerves
E. Lesser palatine nerve
7/30/2019 Oral Cavity Neoplasma
24/42
C
7/30/2019 Oral Cavity Neoplasma
25/42
2. A benign oral cavity lession sometimes mistaken
pathologically for squamous cell carcinoma is
a. Squamous papilloma
b. Granular cell myoblastomac. leukoplakia
d. fibrous histiocytoma
e. erythroplakia
7/30/2019 Oral Cavity Neoplasma
26/42
B
7/30/2019 Oral Cavity Neoplasma
27/42
3. Of oral cavity cancers treated primarily with
radiotherapy for cure, the site treated with the
highest complication rate is the
a. Floor of mouth
b. Tongue
c. buccal mucosa
d. Anterior tonsillar pillar
e. Retromolar trigone
7/30/2019 Oral Cavity Neoplasma
28/42
A
7/30/2019 Oral Cavity Neoplasma
29/42
4. Due to lack of natural barriers in the cheek, buccal
carcinomas, with the following thickness have a
batter prognosis
a. Less than 10 mm
b. Less than 6 mm
c. between 10 and 12 mm
d. Greater than 6 mm
e. Less than or equal to 15 mm
7/30/2019 Oral Cavity Neoplasma
30/42
B
7/30/2019 Oral Cavity Neoplasma
31/42
5. Primary malignancies of which oral cavity site are
equally distributed between salivary gland and
squamous cell carcinoma
a. Floor of mouth
b. Anterior tonsillar pillar
c. hard palate
d. Tongue
e. Buccal mucosa
7/30/2019 Oral Cavity Neoplasma
32/42
C
7/30/2019 Oral Cavity Neoplasma
33/42
6. Alveolus carcinomas are most commonly located
in the
a. Anterior maxillary segment
b. Posterior third of the mandible
c. anterior mandibular arch
d. Body of mandible
e. Posterior alveolus
7/30/2019 Oral Cavity Neoplasma
34/42
B
7/30/2019 Oral Cavity Neoplasma
35/42
7/30/2019 Oral Cavity Neoplasma
36/42
7/30/2019 Oral Cavity Neoplasma
37/42
7/30/2019 Oral Cavity Neoplasma
38/42
C
7/30/2019 Oral Cavity Neoplasma
39/42
9. The most common surgical reconstructive
technique for the resurfacing of oral cavity defects
after oncologic resection is
a. Full-thickness skin graft
b. Split-thickness skin graft
c. radial forearm free flap
d. Tongue flap
e. Myocutaneous flap
7/30/2019 Oral Cavity Neoplasma
40/42
B
7/30/2019 Oral Cavity Neoplasma
41/42
7/30/2019 Oral Cavity Neoplasma
42/42
D